Orthostatic blood pressure changes and incident atrial fibrillation in patients with hypertension: Insights from the SPRINT trial

30 August 2024 (15:00 - 15:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Jue Wang

Beijing (China)

8 More presentations in this session

Presentation thumbnail

Diagnostic and prognostic value of ECG-predicted hypertension mediated left ventricular hypertrophy using machine learning

Doctor H. Naderi (London, GB)

Abstract Slides Video

Presentation thumbnail

Carotid-Femoral pulse wave velocity progression in hypertensive patients is associated with subsequent cardiovascular outcomes

Doctor A. Maloberti (Milan, IT)

Abstract Slides Video

Presentation thumbnail

Cardiac magnetic resonance (CMR) height-based allometric scaling in Southeast Asians; implications in the diagnosis and prognosis of left ventricular hypertrophy (LVH): the REMODEL study

Mr C. Lee (Dundee, GB)

Abstract Slides Video

Presentation thumbnail

Relationship between renin, aldosterone, aldosterone-to-renin ratio and left ventricular mass index in young adults

Doctor R. Ananda (Melbourne, AU)

Abstract Slides Video

Presentation thumbnail

Impact of changes in left heart geometry on predicting new-onset atrial fibrillation in patients with hypertension

Assistant Professor H. KIM (Seoul, KR)

Abstract Slides Video

Access the full session

Session thumbnail

Hypertension target organ damage

The Event

Event poster

ESC Congress 2024

30 August 2024 15:00 CET

You may be interested in

Congress Presentation

Supine hypertension as a predictor of atrial fibrillation: a UK biobank cohort study

Congress Presentation

Relative blood pressure increase is associated with subsequent atrial fibrillation episodes in long-term out-patient monitoring: TriggersAF

Congress Presentation

Changing the game for new AF screening initiatives

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources